Crucially, network analyses of gene coexpression profiles typically used in AD research are not designed to capture these synergistic TF combinations, resulting in a fragmented mechanistic understanding of the gene programs underlying AD progression and, most likely, missed therapeutic opportunities. This evidence concerns the gene TF and Alzheimer disease.